No Detail Found!

Development of potent remdesivir derivative against SARS-CoV-2 protease inhibitors: Design, modification, molecular modeling and MD simulations

Author(s)
Mahwish Akhtar Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Sumbul Shamim Department of Pharmacology, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Abstract
The pandemic Coronavirus (Covid-19) is continuously growing and spreading at the highest rate in all over the world. So, it is necessary to produce the new medicinal agents against this virus. The aim of the present study is to design a potent compound against COVID-19. Based on 3C-like main protease and recently developed solved structure (PDB ID: 6Y2F), a series of remdesivir analogs are designed and analyzed by employing molecular modeling against the SARS-CoV-2 by insilico approach. The molecular dynamics (MD) simulation for 500ps was performed to check the stability and orientation to inside the binding pocket for analogs R3, R9, R14 and R15. The study results exhibit that compsound R9 has strong interaction or least binding energy (-10.04kcal/mol) as compare to the other analogues due to the presences of methyl bromide and it may be useful to further investigation in vitro testing against Covid-19.
Publication Details
Page(s) 1119-1126
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP3, Year: 2021

Request the full text from PASTIC

Keywords
3C-like protease, Docking study, drug designing, Remdesivir, SAR-COV-2
References
Al-Tannak NF,Novotny L,Alhunayan A .2020 .Remdesivir-bringing hope for COVID-19 treatment. , 88(2) : 29.
Pak. J. Pharm. Sci. ,Palm GJ,Mesters JR,Siddell SG,Ziebuhr J,Hilgenfeld R .2002 .Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J, 21(13) : 3213-3224.
Bacha U,Barrila J,Velazquez-Campoy A,Leavitt SA,Freire E .2004 .Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochem., 43(17) : 4906-4912.
Brooks BR,Brooks 3rd CL,Mackerell Jr AD,Nilsson L,Petrella RJ,Roux B,Won Y,Archontis G,Bartels C,Boresch S,Caflisch A,Caves L,Cui Q,Dinner AR,Feig M,Fischer S,Gao J,Hodoscek M,Im W,Kuczera K,Lazaridis T,Ma J,Ovchinnikov V,Paci E,Pastor RW,Post CB,Pu JZ,Schaefer M,Tidor B,Venable RM,Woodcock HL,Wu X,Yang W,York DM,Karplu M DM .2009 .CHARMM: The biomolecular simulation program. J. Comput. Chem, 30(10) : 1545-1614.
Cao Y,Deng QX,Dai SX .2020 .Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Med Infect Dis, 35 : 101647.
ChemOffice .2009 .. ChemOffice 6, : .
Dassault Systèmes BIOVIA .2017 .Discovery Studio Modeling Environment, Release. , : .
Darden T,York D,Pedersen L D .1993 .Particle mesh Ewald: An N·log (N)method for Ewald sums in large systems. J. Chem. Phys., 98(12) : 10089-10092.
Eastman RT,Roth JS,Brimacombe KR,Simeonov A,Shen M,Patnaik S,Hall MD .2020 .Remdesivir: A review of its discovery and development leading to emergency use authorization for treatment of COVID19. ACS Cent. Sci., 6(5) : 672-683.
Elfiky AA .2020 .Ribavirin, Remdesivir, Sofosbuvir, Galidesivir and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study, Life Sci. , 15(253) : 117592.
Elfiky AA .2020 .SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. J. Biomolec Struct Dyna, 1761882 : .
Fung TS,Liu DX .2019 .Human coronavirus: Hostpathogen interaction. Annu. Rev. Microbiol., 73 : 529-557.
Humphrey W,Dalke A,Schulten K A .1996 .Visual molecular dynamics. J. Mol. Graph, 14(1) : 8-38.
Jorgensen WL,Chandrasekhar J,Madura JD,Impey RW,Klein ML .1983 .Comparison of simple potential functions for simulating liquid water. J. Chem. Phys., 79(2) : 926-935.
Koulgi S,Jani V,Uppuladinne MVN,Sonavane U,Joshi R U .2020 .Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus. RSC Adv, 10(45) : 26792.
Kumar Y,Singh H,Patel CN H .2020 .In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J. Infect. Public Health, 13(9) : 1210-1223.
MacKerell AD,Bashford D,Bellott M,Dunbrack RL,Evanseck JD,Field MJ,Fischer S,Gao J,Guo H,Ha S,Joseph-McCarthy D,Kuchnir L,Kuczera K,Lau FTK,Mattos C,Michnick S,Ngo T,Nguyen DT,Prodhom B,Reiher WE,Roux B,Schlenkrich M,Smith JC,Stote R,Straub J,Watanabe M,Wiórkiewicz-Kuczera J,Yin D,Karplus M .1998 .All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B., 102(18) : 3586-3616.
Pastor RW,Brooks BR,Szabo A .1988 .An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol. Phys., 65(6) : 1409-1419.
Pizzorno A,Padey B,Julien T,Assant ST,Traversier A,Cerda EE,Fouret J,Dubois J,Gaymard A,Lescure FX,Dulière V,Brun P,Constant S,Poissy J,Lina B,Yazdanpanah Y,Terrier O,Calatrava MR .2020 .Characterization and treatment of SARSCoV-2 in nasal and bronchial human airway epithelia. Cell reports Med, 1(4) : 100059.
PyMOL; The PyMOL Molecular Graphics System . .. Version 2.0 Schrodinger, : .
Salentin S,Schreiber S,Haupt VJ,Adasme MF,Schroede M .2015 .PLIP: Fully automated protein-ligand interaction profiler. Nucl. Acids Res, 43(W1) : W443-W447.
Shannona A,Lea TTL,Seliskoa B,Eydouxa C,Alvareza K,Guillemots JC,Decrolya E,Peersenb O,Ferrona F,Canarda B,Sheahan TP,Sims AC,Leist SR,Schäfer A,Won J,Brown AJ,Montgomery SA,Hogg A,Babusis D,Clarke MO,Spahn JE,Bauer L,Sellers S,Porter D,Feng JY,Cihlar T,Jordan R,Denison MR,Baric RS .2020 .Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERSCoV. Anti Res., 11 : 222.
Olson Trott O,AJ Trott O .2010 .Auto Dock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem, 31(2) : 455-461.
Wang M,Coa R,Zhang L,Yang X,Liu J,Xu M,Shi Z,Hu Z,Zhong W,Xiao G .2020 .Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res, 30(3) : 269-271.
Williamson BEN,Feldmann F,Schwarz B MeadeWhite K DP,Schulz J,Doremalen NV,Leighton I,Yinda CK,Pérez-Pérez L,Okumura A,Lovaglio J,Hanley PW,Saturday G,Bosio CM,Anzick S,Barbian K,Cihlar T,Martens C,Scott DP,Munster VJ .2020 .Clinical benefit of remdesivir in rhesus macaques infected with SARSCoV-2. , 585(issue) : 273-276.
Wrapp D,Wang N,Corbett KS,Goldsmith J A,Hsieh CL,Olubukola A .2020 .Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Bio, 367(6483) : 1260-1263.
Xu X,Ping Chen P,Jingfang Wang J,Feng J,Zhou H,Xuan Li X,Zhong W,Hao P .2020 .Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. , 63(3) : 457-460.
Zhang L,Lin D,Sun X,Curth U,Drosten C,Sauerhering L,Becker S,Rox K,Hilgenfeld R K .2020 .Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. , 368(6489) : 409-412.
Zhang XW,Yap YL .2004 .Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. Bioorg Med, 12(10) : 2517-2521.
0

Citations

0

Downloads

8

Views